Clinical Trials Browser

Carcinoma, Basal Cell, Melanoma, Skin Neoplasms

NCT07148245 2025-11-10

Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma

Recruiting

300 enrolled

Dermatologic

Melanoma

NCT06605404 2025-08-14

Pan-tumor MRD Study

Recruiting

1,350 enrolled

DermatologicGastrointestinalThoracic

Adenocarcinoma, Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Melanoma

NCT05819827 2025-04-27

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

Terminated

13 enrolled

DermatologicGenitourinarySarcoma

Urinary Bladder Neoplasms, Melanoma, Prostatic Neoplasms, Sarcoma, Testicular Neoplasms

NCT05940311 2024-11-27

VerSiLiB

Recruiting

20 enrolled

Dermatologic

Melanoma

NCT03267381 2023-12-14

Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy

Completed

37 enrolled

Dermatologic

Melanoma

NCT05817149 2023-04-18

Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study

Completed

20 enrolled

Dermatologic

Melanoma

NCT00507325 2022-09-02

Sample Collection From Melanoma Patients

Terminated

131 enrolled

Dermatologic

Melanoma, Neoplasms

NCT02907086 2022-06-06

Circulating Tumor Material in Colorectal Cancer and Melanoma

Completed

7 enrolled

DermatologicGastrointestinal

Melanoma, Colorectal Neoplasms

NCT04154163 2022-02-28

ADOPT

Completed

18 enrolled

DermatologicGenitourinaryGynecologicThoracic

Carcinoma, Non-Small-Cell Lung, Kidney Neoplasms, Melanoma, Ovarian Neoplasms

NCT04136470 2020-08-10

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Unknown

130 enrolled

DermatologicThoracic

Carcinoma, Non-Small-Cell Lung, Melanoma, Neoplasms

NCT04493723 2020-07-30

Serial Tumour Biopsies and Blood Biomarkers in Melanoma

Recruiting

300 enrolled

Dermatologic

Melanoma

NCT01528774 2017-07-26

CTC

Completed

150 enrolled

DermatologicGenitourinarySarcoma

Kidney Neoplasms, Melanoma, Neoplastic Cells, Circulating, Prostatic Neoplasms, Sarcoma, Somatostatinoma

NCT00615095 2011-04-20

Differential Risks for Melanoma: p16 and DNA Repair

Completed

323 enrolled

Dermatologic

Melanoma

Clinical Trials

Liquid Biomarker Study in Melanoma and Non-Melanoma Skin Cancers

Symptoms of Immune Checkpoint Inhibitor Therapy in Cutaneous Melanoma

Pan-tumor MRD Study

Associations Between Chemotherapy-Induced Nausea in Patients With Genitourinary, Sarcoma or Melanoma Cancers and Changes in Gut Microbiome: Potential for Precision Therapeutics

VerSiLiB

Circulating Blood Profile to Predict Recurrence and Response to Systemic Therapy

Perioperative Examination of Inflammatory Markers in Relation to Sentinel Lymph Node Biopsy in Patients With Melanoma; a Pilot Study

Sample Collection From Melanoma Patients

Circulating Tumor Material in Colorectal Cancer and Melanoma

ADOPT

BioForte Technology for in Silico Identification of Candidates for a New Microbiome-based Therapeutics and Diagnostics

Serial Tumour Biopsies and Blood Biomarkers in Melanoma

CTC

Differential Risks for Melanoma: p16 and DNA Repair